文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

肠易激综合征与糜烂性食管炎重叠及罗马标准在临床环境中诊断肠易激综合征的表现。

Overlapping of irritable bowel syndrome with erosive esophagitis and the performance of Rome criteria in diagnosing IBS in a clinical setting.

机构信息

Section for Gastroenterology, Department of Medicine, Stord Hospital, 5416 Stord, Norway.

Department of Clinical Medicine, University of Bergen, 5007 Bergen, Norway.

出版信息

Mol Med Rep. 2019 Jul;20(1):787-794. doi: 10.3892/mmr.2019.10284. Epub 2019 May 23.


DOI:10.3892/mmr.2019.10284
PMID:31180516
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6580027/
Abstract

Irritable bowel syndrome (IBS) and gastroesophageal reflux disease (GERD) overlap. It is not clear whether GERD is caused by non‑erosive esophagitis, or erosive esophagitis. The Rome criteria are not widely used for the diagnosis of IBS in the clinic. In total, 1,489 IBS patients without red flags were included in the present retrospective study. They comprised of 1,331 females and 158 males with a mean age of 51 years. The diagnosis of IBS was verified by endoscopic and histopathological examinations. Whereas erosive esophagitis occurred in 97% of patients, only 66% had GERD symptoms. Endoscopy and histopathological examinations revealed that 1.4% of the IBS patients with diarrhea as the predominant symptom had other organic gastrointestinal diseases: 0.3% with celiac disease, 0.2% with Crohn's disease, 0.07% with ulcerative colitis, 0.6% with microscopic colitis, and 0.2% with colon cancer. Applying the Rome III criteria produced a sensitivity of 100% [95% confidence intervals (CI)=99.8‑100.0%] a specificity of 98.7% (95% CI=98.0‑99.2%), a positive likelihood ratio of 76.9%, and a negative likelihood ratio of 0%. IBS is associated with erosive esophagitis. Applying Rome III criteria without red flags and history, was effective in diagnosing IBS. Celiac disease and microscopic colitis should be considered as alternative diagnoses.

摘要

肠易激综合征(IBS)和胃食管反流病(GERD)重叠。目前尚不清楚 GERD 是否由非糜烂性食管炎或糜烂性食管炎引起。罗马标准在临床上并未广泛用于 IBS 的诊断。本回顾性研究共纳入 1489 例无报警症状的 IBS 患者,其中女性 1331 例,男性 158 例,平均年龄 51 岁。IBS 的诊断通过内镜和组织病理学检查得到验证。虽然 97%的患者存在糜烂性食管炎,但仅有 66%的患者有 GERD 症状。内镜和组织病理学检查显示,以腹泻为主要症状的 IBS 患者中,有 1.4%患有其他器质性胃肠道疾病:0.3%患有乳糜泻,0.2%患有克罗恩病,0.07%患有溃疡性结肠炎,0.6%患有显微镜结肠炎,0.2%患有结肠癌。应用 Rome III 标准的敏感性为 100%(95%置信区间[CI]=99.8-100.0%),特异性为 98.7%(95% CI=98.0-99.2%),阳性似然比为 76.9%,阴性似然比为 0%。IBS 与糜烂性食管炎有关。应用 Rome III 标准且无报警症状和病史,对 IBS 的诊断有效。乳糜泻和显微镜结肠炎应作为替代诊断。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d374/6580027/7a211bad7ded/MMR-20-01-0787-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d374/6580027/86283fa94af0/MMR-20-01-0787-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d374/6580027/be7244aa776a/MMR-20-01-0787-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d374/6580027/2321939f9b73/MMR-20-01-0787-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d374/6580027/a717ed5b651b/MMR-20-01-0787-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d374/6580027/7a211bad7ded/MMR-20-01-0787-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d374/6580027/86283fa94af0/MMR-20-01-0787-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d374/6580027/be7244aa776a/MMR-20-01-0787-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d374/6580027/2321939f9b73/MMR-20-01-0787-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d374/6580027/a717ed5b651b/MMR-20-01-0787-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d374/6580027/7a211bad7ded/MMR-20-01-0787-g04.jpg

相似文献

[1]
Overlapping of irritable bowel syndrome with erosive esophagitis and the performance of Rome criteria in diagnosing IBS in a clinical setting.

Mol Med Rep. 2019-5-23

[2]
Validation of the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care.

Gastroenterology. 2013-8-28

[3]
Rome III survey of irritable bowel syndrome among ethnic Malays.

World J Gastroenterol. 2012-11-28

[4]
The prevalence of coeliac disease in patients fulfilling Rome III criteria for irritable bowel syndrome.

Arab J Gastroenterol. 2016-6

[5]
Prodromal irritable bowel syndrome may be responsible for delays in diagnosis in patients presenting with unrecognized Crohn's disease and celiac disease, but not ulcerative colitis.

Dig Dis Sci. 2011-6-22

[6]
Patients suspected of irritable bowel syndrome--cross-sectional study exploring the sensitivity of Rome III criteria in primary care.

Am J Gastroenterol. 2013-2-19

[7]
Irritable bowel syndrome is associated with gastroesophageal reflux symptom but not erosive esophagitis.

J Neurogastroenterol Motil. 2013-10-7

[8]
Prevalence of organic disease at colonoscopy in patients with symptoms compatible with irritable bowel syndrome: cross-sectional survey.

Scand J Gastroenterol. 2015-7

[9]
Overlapping gastroesophageal reflux disease and irritable bowel syndrome: increased dysfunctional symptoms.

World J Gastroenterol. 2010-3-14

[10]
[A comparison between Rome III and Rome II criteria in diagnosing irritable bowel syndrome].

Zhonghua Nei Ke Za Zhi. 2007-8

引用本文的文献

[1]
Quality of life, functional impairment and healthcare experiences of patients with irritable bowel syndrome in Norway: an online survey.

BMC Gastroenterol. 2025-3-6

[2]
Rectal Hypersensitivity in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.

Crohns Colitis 360. 2021-6-23

[3]
Overlap between irritable bowel syndrome and common gastrointestinal diagnoses: a retrospective cohort study of 29,553 outpatients in Germany.

BMC Gastroenterol. 2022-2-5

[4]
Fecal microbiota transplantation for irritable bowel syndrome: An intervention for the 21 century.

World J Gastroenterol. 2021-6-14

[5]
The role of diet in the pathophysiology and management of irritable bowel syndrome.

Indian J Gastroenterol. 2021-4

[6]
Density of Musashi‑1‑positive stem cells in the stomach of patients with irritable bowel syndrome.

Mol Med Rep. 2020-10

[7]
Possible role of intestinal stem cells in the pathophysiology of irritable bowel syndrome.

World J Gastroenterol. 2020-4-7

[8]
Diet in Irritable Bowel Syndrome (IBS): Interaction with Gut Microbiota and Gut Hormones.

Nutrients. 2019-8-7

本文引用的文献

[1]
Modern diagnosis of GERD: the Lyon Consensus.

Gut. 2018-2-3

[2]
Enteroendocrine, Musashi 1 and neurogenin 3 cells in the large intestine of Thai and Norwegian patients with irritable bowel syndrome.

Scand J Gastroenterol. 2017-12

[3]
Chromogranin A cell density in the large intestine of Asian and European patients with irritable bowel syndrome.

Scand J Gastroenterol. 2017

[4]
Irritable bowel syndrome: what do the new Rome IV diagnostic guidelines mean for patient management?

Expert Rev Gastroenterol Hepatol. 2017-4

[5]
What Is New in Rome IV.

J Neurogastroenterol Motil. 2017-4-30

[6]
Derivation and validation of a diagnostic test for irritable bowel syndrome using latent class analysis.

Aliment Pharmacol Ther. 2017-3

[7]
Enhancing Diagnostic Performance of Symptom-Based Criteria for Irritable Bowel Syndrome by Additional History and Limited Diagnostic Evaluation.

Am J Gastroenterol. 2016-10

[8]
Rome IV Diagnostic Questionnaires and Tables for Investigators and Clinicians.

Gastroenterology. 2016-2-13

[9]
The relation between celiac disease, nonceliac gluten sensitivity and irritable bowel syndrome.

Nutr J. 2015-9-7

[10]
Recent developments in the pathophysiology of irritable bowel syndrome.

World J Gastroenterol. 2015-7-7

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索